Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

INCOME TAXES

v3.21.1
INCOME TAXES
12 Months Ended
Dec. 31, 2020
Text block [abstract]  
INCOME TAXES
10.
INCOME TAXES
 
(a)
Current income taxes
 
Below is a reconciliation of combined federal and provincial corporate income taxes at the company’s effective rate of 26.5% (2019: 26.5%).

   
December 31, 2020
   
December 31, 2019
 
Net loss before income taxes
 
$
(24,184,657
)
 
$
(41,907,079
)
Income taxes at statutory rates
   
(6,408,934
)
   
(11,105,376
)
Tax effect of expenses not deductible for income tax purposes:
               
Permanent differences
   
7,648,554
     
(4,800,780
)
Unrecognized share issue costs
   
(129,264
)
   
(625,220
)
Tax / foreign rate changes and other adjustments
   
(49,409
)
   
93,724
 
Total tax recovery
   
1,060,947
     
(16,437,652
)
Tax recovery not recognized
   
(1,060,947
)
   
16,437,652
 
   
$
-
   
$
-
 

(b)
Deferred income taxes
 
Deferred income tax assets and liabilities result primarily from differences in recognition of certain timing differences that give rise to the Company’s future tax assets (liabilities) and are as follows:

   
December 31, 2020
   
December 31, 2019
 
Non-capital losses
 
$
62,773,915
   
$
63,740,497
 
Qualifying research and development expenditure
   
1,493,309
     
1,493,309
 
Share issue costs and other
   
1,868,633
     
1,999,584
 
Total tax assets
   
66,135,857
     
67,233,390
 
Tax assets not recognized
   
(66,135,857
)
   
(67,233,390
)
Net deferred tax assets
 
$
-
   
$
-
 

In assessing the realizability of deferred tax assets, management considers whether it is probable that some or all the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Management, based on IFRS criteria, has determined, at this time, not to recognize its deferred tax assets.
 
 
(c)
Losses carried forward
 
The Company has non-capital losses of approximately $236,882,697 available to reduce future income taxes. The non-capital losses expire approximately as follows:
 
 
Expiry year
 
Non-capital losses
 
 
2031
 
$
9,674,326
 
 
2032
   
10,454,774
 
 
2033
   
10,210,370
 
 
2034
   
13,784,437
 
 
2035
   
43,934,918
 
 
2036
   
28,260,911
 
 
2037
   
19,604,159
 
 
2038
   
40,239,997
 
 
2039
   
60,718,805
 
     
$
236,882,697
 

The Company has accumulated Qualifying Research and Development expenses of $5,635,128 from prior years research and development. These expenditures may be carried forward indefinitely and used to reduce taxable income in future years.
 
As a result of a Canada Revenue Agency (CRA) audit completed in 2017 and 2016, regarding Titan’s 2012 and 2011 SR&ED claim, the 2012 loss of $6,517,436 has been adjusted to $7,260,729 and the 2011 loss of $9,423,694 has been adjusted to $12,735,836. The qualifying SR&ED expenditures has also been adjusted from $9,439,430 to $5,635,128. CRA concluded that the claimed work did not satisfy the SR&ED criteria. Titan is appealing this decision by CRA.
 
(d)
Investment tax credits
 
At December 31, 2020, the Company has $1,167,560 (2019 - $1,167,560) of unclaimed investment tax credits available to reduce federal income taxes payable in future years. If not utilized, these investment tax credits will start expiring in 2028. The amounts have been adjusted to reflect changes due to the CRA audit.
 
At December 31, 2020, the Company has $237,997 (2019 - $237,997) of unclaimed Ontario Research and Development Tax Credit available to reduce Ontario income taxes payable in future years. If not utilized, this credit will start expiring in 2029. The amounts have been adjusted to reflect changes due to the CRA audit.